astrazeneca news - Search News

AstraZeneca, China

AstraZeneca talks up US growth as China problems fester

AstraZeneca Plc is increasingly looking to the US for growth as its once fast-expanding China business faces challenges amid a probe that has battered the drugmaker’s share price.

The Financial Times · 2d

AstraZeneca chief says group takes China probe ‘very seriously’

AstraZeneca chief executive Pascal Soriot said the company took the detention of its China president “very seriously”, as the drugmaker raised its guidance for a second straight quarter on the back of strong sales of cancer medicines.

Reuters on MSN · 1d

AstraZeneca CEO says detained China chief has a lawyer but 'we have no information'

AstraZeneca's CEO said on Tuesday that the company's China president Leon Wang, who last month was detained by Chinese authorities, has a lawyer he is in touch with, but "we have no information as a company".

Barron's · 2d

Pharma Giant AstraZeneca Takes China Probes 'Very Seriously'

British pharmaceutical giant AstraZeneca on Tuesday said it takes "very seriously" China's investigations into potential illegal data collection and drug imports by the group that caused the detention of its China boss.

21hon MSN

Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...

1don MSN

AstraZeneca lifts 2024 outlook after Q3 beat, doubles down on US investments

Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...

Daily49m

AstraZeneca, Daiichi Sankyo submits Datopotamab deruxtecan new BLA for accelerated approval in US for lung cancer

AstraZeneca and Daiichi Sankyo have submitted a new Biologics License Application (BLA) for accelerated approval in the US ...

Hosted on MSN1d

AstraZeneca Expands U.S. Investment Plan

AstraZeneca said it plans to pump $2 billion in new investment into the U.S., one of the first major foreign companies to ...

AstraZeneca says detained China head has lawyer, but company still in dark

AstraZeneca's China president Leon Wang, who was detained last month by Chinese authorities, is in touch with a lawyer but ...

STAT1d

Pharmalittle: We’re reading about 23andMe retrenching, AstraZeneca reworking cancer drug plans, and more

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

Bisnow15h

AstraZeneca To Invest $3.5B To Grow U.S. Footprint

Cambridge, England-based biopharmaceutical giant AstraZeneca is pouring billions of dollars into properties in the United ...

12h

AstraZeneca: Strong Growth Potential And Market Volatility Offer Opportunity

AstraZeneca PLC aims for $80 billion revenue by 2030 through strong growth in oncology, biopharmaceuticals, and rare diseases ...

STAT2d

AstraZeneca, Daiichi Sankyo change strategy on closely watched cancer drug

LONDON — AstraZeneca said Tuesday it has had to resubmit a closely watched medicine for U.S. approval in a different form of ...

14h

AstraZeneca Director Bolsters Stake with Share Purchase

AstraZeneca (GB:AZN) has released an update. AstraZeneca’s Senior Independent Non-Executive Director, Philip Broadley, has made a notable ...

The Financial Express1h

AstraZeneca India partners with IAP to raise awareness on RSV in India

RSV symptoms include cough, fever, running nose, irritability, reduced activity, and pauses in breathing. Severe cases can ...

AstraZeneca slumps as Q2 PAT slides 27% YoY to Rs 38 cr

AstraZeneca Pharma tumbled 5.12% to Rs 6,768 after the pharmaceutical firm's net profit declined 26.62% to Rs 38.43 crore in Q2 FY25 as compared with Rs 52.37 crore posted in Q2 FY24.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

AstraZeneca, China

Related topics